期刊文献+

腹膜透析228例临床分析 被引量:16

Clinical analysis of 228 patients treated with penctoneal dialysis
下载PDF
导出
摘要 目的 :分析总结“O”set腹膜透析装置的治疗情况及体会。方法 :回顾 2 2 8例慢性肾功能衰竭病人腹膜透析前后血压、血红蛋白变化 ,分析腹膜炎、引流不畅发生率及退出腹膜透析的原因。结果 :应用腹膜透析后血压控制较好 ,与透析前相比较血红蛋白上升有显著性 ,腹膜炎与引流不畅是常见并发症 ,并发症导致死亡是病人退出腹膜透析的首要原因。结论 :腹膜透析简便易行 。 Objective To summarize the treatment with peritoneal dialysis with the 'O'set peritoneal dialysis catheter. Methods Reviewing the 228 cases of chronic renal failure patients, we compared their blood pressure and hemoglobin before peritoneal dialysis with those after peritoneal dialysis, observed the morbidity of peritonitis and drainage block, and analyzed reasons that the patients withdrew from peritoneal dialysis. Results The patients' blood pressures were controlled very well after peritoneal dialysis. Hemoglobin increased significantly, compared with that before peritoneal dialysis. Death caused by complications of peritoneal dialysis was the primary reason that the patients withdrew from peritoneal dialysis. Conclusion Peritoneal dialysis is simple, convenient, safe and efficient.
出处 《湖南医科大学学报》 CSCD 北大核心 2002年第1期74-76,共3页 Bulletin of Hunan Medical University
关键词 腹膜透析 高血压 贫血 肾功能衰竭 血压 血红蛋白 peritoneal dialysis hypertension aremia renal failure
  • 相关文献

参考文献9

  • 1[1]Oreopoulos DG. Peritoneal dialysis in the past 20 years: An excting journey[J]. Peril Dial Int, 1999,19(suppel 3):3-8.
  • 2[2]Kim MJ, Lee SW, Yang HJ. Influence of CAPD on blood pressure using anbulatory blood pressure monitoring[J]. Perit Dial Int, 1999,19(suppl 1):55.
  • 3[3]Besarab M. Recombinant Human erythropoietin: physiology, pathophysiology of anemia in renal failure and economic aspects to dosing[J]. Am J Nephrol, 1990,10(supple 2):2.
  • 4[4]Joseph W, Eschbach MD, Joan C, et al. Correction of the anemia of end-stage renal disease with ricombinant human erythropoietin: Results of a combined phase I and II clinical trial[J]. New Eng J of Med, 1987,8:73-79.
  • 5[5]Horl WH. How to get the best out of r-Hu EPO[J]. Nephron Dial Transplant, 1995,10(supple 2):92.
  • 6[6]Sloand JA, Shelley MA, Erenstone AL, et al. Safety and efficacy of total dose iron dextran administration in patients on home renal replacement therapies[J]. Perit Dial Int, 1998,18:522-527.
  • 7[7]Ekstrand A, Kala AR, Tevanen R, et al. Why do patients fail on peritoneal dialysis[J]. Pent Dral Int, 1999,19(supple 1):53.
  • 8[8]Viglino G, Salomone M, Gabella P, et al. Pentonitis in PD: 15 years of italian PD study group[J]. Pent Dial Int, 1998,19(supple 1):38.
  • 9[9]Gentil MA, Carriazo A, Pavon MI, et al. Comparison of survival in continuous ambulatory peritoneal dialysis and hospital hemodialysis: A multicentric study[J]. Nephrol Dial Transplant, 1991,6:444.

同被引文献119

引证文献16

二级引证文献78

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部